Newsletter – July 2022

Newsletter – July 2022

 From nature to patients…. Fellow stakeholders – we are in a great position entering into the 2022-23 financial year! With improved patient access and steady growth in GP’s prescribing medicinal cannabis for a variety of treatments, our company is strategically...
Newsletter – June 2021

Newsletter – June 2021

From patients, to patients….. The 2020-21 financial year will no doubt be remembered as a significant one for many people! Having closely monitored trends in the global cannabis industry, the Board has made a conscious decision to pivot the short-term strategic...
Newsletter – March 2021

Newsletter – March 2021

From patients, to patients…..Since being granted a MC Import license in late 2020, Sativite has sourced a range of premium Medicinal Cannabis products from strategic partners around the globe – including Jamaica, Canada and the United states. “These premium products...